Canadian Cancer Trials Group Bulletins


Recent Publications

Canadian Cancer Trials Group PRP.1 - Primary
A Double-Blind, Placebo-Controlled, Randomized Study of Combination Vitamin E, Selenium and Soy Protein Product in Subjects with High Grade Prostatic Intraepithelial Neoplasia

Fleshner NE, Kapusta L, Donnelly B, Tanguay S, Chin J, Hersey K, Farley A, Jansz K, Siemens DR, Trpkov K, Lacombe L, Gleave M, Tu D, Parulekar WR. Progression From High-Grade Prostatic Intraepithelial Neoplasia to Cancer: A Randomized Trial of Combination Vitamin-E, Soy, and Selenium (ONLINE). J Clin Oncol 2011.

Canadian Cancer Trials Group MA.5 - Online April 25, 2011
Cooperative Clinical Trial of Intensive CEF versus Standard CMF as Adjuvant Therapy for Breast Carcinoma in Premenopausal Patients With Histologically Involved Axillary Nodes

O'Malley FP, Chia S, Tu D, Shepherd LE, Levine MN, Huntsman D, Bramwell VH, Andrulis IL, Pritchard KI. Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the Canadian Cancer Trials Group randomized MA.5 adjuvant trial (ONLINE). Breast Cancer Res Treat , 2011.